- 41 of Pfizer’s drugs have been picked for a price hike on January 15, averaging 5%.
- Pfizer noted Friday that the increases will be offset by higher rebates and discounts offered to insurance companies and pharmacy benefit managers.
- Pfizer had the highest profit total ($4.1 billion) of any publicly traded health care company in the third quarter.
SUMMARY: Pfizer’s merger with Allergan is not about developing new and better drugs for patients, it’s about saving a bundle of money on taxes and while it’s legal it doesn’t make it right. Continue reading
Pfizer is adding humor to the battle over the post-menopause prescription market. Launched last week the “Let’s talk about change” campaign is a departure from the company’s recent “Tune into Menopause” campaign that featured Kim Cattrall. As someone who has sat in a LOT of research with women this YouTube video really misses the mark. Continue reading
The 50 Happiest Companies in America is an annual awards list of the companies that keep their employees the happiest. Pfizer was voted the happiest company in America by its own workers for the second year running, according to an annual survey from job site CareerBliss. The winners have been voted by their very own employees as a happy, rewarding place to work. To determine the top happiest companies, CareerBliss analyzes thousands of independent employee-submitted reviews. The reviews ask professionals to rank how they feel about key happiness factors at work, such as the culture of the company, compensation and people you work. Given the massive layoffs pharma has gad over the last couple of years it’s good to see those remaining are happy with Pfizer. Continue reading
U.S. regulators and the drug industry want to extend by two months the deadline for the Food and Drug Administration to approve or reject new drugs. The FDA said it would need an extra 60-day “filing date” before the clock starts ticking on its 10-month deadline to review new drugs, or six months for a priority review. This means even less time on the market to recoup costs and is one of the reasons why new drug prices are going to continue to climb. Continue reading